Whilst research ethics committees (RECs) exist to represent society's interests by placing appropriate checks on the economic power of ‘big pharma’, the political sphere is here seen to have generally acquiesced to economic interests and allowed industry to influence how it is regulated. RECs are accordingly urged to remain vigilant about the prospects of their being the subject of hidden influences.
References
1.
BrungerFBurgessM. A cultural understanding of research ethics governance. Health Law Review2005; 13(2 & 3):69–74.
LedererSE. Research without borders: the origins of the Declaration of Helsinki. In RoelckeVMaioG (eds). Twentieth century ethics of human subjects research: historical perspectives on values, practices and regulations. Stuttgart: Franz Steiner Verlag2004:199–215.
7.
International Ethical Guidelines for Biomedical Research Involving Human Subjects. CIOMS available at www.cioms.ch/frame-guidelines-nov-2002.htm (last accessed 20 March 2007).
HomanR. Problems with codes. Res Ethics Rev2006; 2(3): 98–103.
10.
Directive 2001/20/EC of the European Parliament and the Council of 4th April 2001 on the approximation of laws, regulations and administrative provisions relating to the implementation of good ethical practice in the conduct of clinical trials on medicinal products for human use. The European Parliament, 2001. Available at europa.eu/eurlex/pri/en/oj/dat/2001/l-121/l-12120010501en00340044.pdf.
PerouJ. Which GCP is the right GCP?Clinical Discovery2006; (April-May):10–11.
13.
LunaF. Assumptions in the ‘standard of care’ debate. In CohenJCIllingworthPSchuklenkU (eds). The power of pills: social, ethical & legal issues in drug development, marketing & pricing. London: The Pluto Press, 2006: 215–23.
14.
LevineRJ. Revision of the CIOMS International Ethical Guidelines: a progress report. In LevineRJGorovitzS (eds). Biomedical research ethics: updating international guidelines. Geneva:CIOMS, 2000.
15.
BeyleveldDBrownswordRWallaceS. Independent ethics committees in the United Kingdom. In LeBeerG (ed). Ethical function in hospital ethics committees. Amsterdam:IOS Press, 2002.
16.
CaveEHolmS. New governance arrangements for research ethics committees: is facilitating research achieved at the cost of participants’ interest?J Med Ethics2002; 28: 318–21.
17.
GogginMJ. Introduction to the work of research ethics committees in the United Kingdom. 3rd edn. London:ABPI, 2005.
18.
Healthcare Today. April 2006, p19.
19.
BenatarSR. Reflections and recommendations on research ethics in developing countries. Soc Sci Med2002; 54: 1131–41.
20.
LuriePWolfeSM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New Engl J Med1997; 337: 853–56.
21.
DickensBMCookRJ. Challenges of ethical research in resource-poor settings. Int J Gyn Obst2003; 80: 79–86.
22.
MarshallPA. Informed consent in international health research. Journal of Empirical Research in Human Research Ethics2006; 1: 25–42.
23.
The strategic initiative for developing capacity in ethical review at www.sidcer.org (accessed 20 March 2007).
BeecherHK. Ethics and clinical research. New Engl J Medicine1966; 274: 1354–60.
27.
LondonL. Ethical oversight of public health ethics: can rules and IRBs make a difference in developing countries?Am J Publ Hlth2002; 92(7): 1079–84.
28.
PfeifferN. Press release: Independent voice for consumers in research to close. London: CERES2006.
29.
LawJ. Big Pharma: how the world's biggest drug companies control illness. London: Constable2006.
30.
SmithA. FDA Legislation in Transition. Clin Res Focus May2007; 18(5): 23–5.
31.
SayersGM. Should research ethics committees be told how to think?J Med Ethics2007; 33: 39–42.
32.
House of Commons Health Committee. The influence of the pharmaceutical industry: fourth report of session 2004–05. London: The Stationery Office, 2005.
33.
ShahS. The body hunters: testing new drugs on the world's poorest patients. New York: The New Press2006.
34.
EpsteinMWingateDL. Is the NHS research ethics committees system to be outsourced to a low-cost offshore call centre? Reflections on human research ethics after the Warner report. J Med Ethics2007; 33: 45–7.
